Department of Pediatric Radiology, Texas Children's Hospital, 6701 Fannin St., Houston, TX, 77030, USA.
Department of Pediatrics, Section of Pulmonary Medicine, Texas Children's Hospital, Houston, TX, USA.
Pediatr Radiol. 2019 Aug;49(9):1163-1170. doi: 10.1007/s00247-019-04405-5. Epub 2019 Apr 19.
Pleuroparenchymal fibroelastosis (PPFE) may be underdiagnosed clinically and radiographically in children with a remote history of cancer, leading to a delay in care and unnecessary lung biopsies.
To describe the characteristic clinical and radiologic findings of PPFE in a cohort of children to facilitate recognition and noninvasive diagnosis.
Clinical presentation, history of chemotherapy or radiation therapy, lung or bone marrow transplantation, and lung function testing and outcome were retrospectively extracted from the electronic medical records of eight children treated at our institution's pulmonary medicine clinic with histopathology confirmation of PPFE from 2008 to 2018. Two pediatric radiologists evaluated the chest imaging studies for the presence or absence of published radiologic findings of PPFE in adults, including platythorax, pneumothorax, upper lobe predominant pleural and septal thickening, and bronchiectasis. Platythorax indices were calculated from the normal chest CT exams of eight age- and gender-matched individuals obtained via the radiology search engine.
The mean presentation age was 12.9 years (range: 7-16 years). Seven of the eight had a history of chemotherapy and radiation therapy for cancer. Three of the eight had undergone bone marrow transplantation and none had undergone lung transplantation. The mean time between chemotherapy, radiation therapy, and/or bone marrow transplantation and the presentation of PPFE was 8.4 years (range: 5.6-12.1 years). Most of the patients presented with dyspnea (63%), cough (50%) and/or pneumothorax (38%). The mean percentage of predicted FEV1 (forced expiratory volume in one second) was 14.1 (range: 7.7-27.5). All eight patients demonstrated platythorax, bronchiectasis, pleural and septal thickening (upper lobes in four, upper and lower lobes in four) and six had pneumothorax. Five underwent lung biopsies, four of whom developed pneumothoraces.
Clinical and radiologic findings of pediatric PPFE are similar to those in adults, although a majority of the former have a history of treated cancer. Clinical presentation of restrictive lung disease, dyspnea, cough or spontaneous pneumothorax years after treatment for childhood cancer combined with platythorax, upper lobe pleural and septal thickening and traction bronchiectasis on chest CT establishes a presumptive diagnosis of PPFE.
在有癌症病史的儿童中,胸膜肺弹力纤维增生症(PPFE)可能在临床上和放射学上被误诊,导致治疗延误和不必要的肺活检。
描述一组儿童中 PPFE 的特征性临床和放射学表现,以促进识别和非侵入性诊断。
回顾性提取了 2008 年至 2018 年期间在我院肺科诊所接受治疗的 8 例经组织病理学证实的 PPFE 患儿的临床表现、化疗或放疗史、肺或骨髓移植以及肺功能检测和结局。两名儿科放射科医生评估了胸部影像学研究,以确定是否存在成人 PPFE 的已发表放射学发现,包括扁平胸、气胸、上叶为主的胸膜和间隔增厚以及支气管扩张。从通过放射学搜索引擎获得的 8 名年龄和性别匹配个体的正常胸部 CT 检查中计算了扁平胸指数。
中位发病年龄为 12.9 岁(范围:7-16 岁)。8 例中有 7 例有癌症的化疗和放疗史。8 例中有 3 例接受了骨髓移植,无肺移植。化疗、放疗和/或骨髓移植与 PPFE 表现之间的平均时间为 8.4 年(范围:5.6-12.1 年)。大多数患者表现为呼吸困难(63%)、咳嗽(50%)和/或气胸(38%)。预测的 1 秒用力呼气量(forced expiratory volume in one second,FEV1)的平均百分比为 14.1(范围:7.7-27.5)。8 例患者均表现为扁平胸、支气管扩张、胸膜和间隔增厚(4 例为上叶,4 例为上下叶),6 例有气胸。5 例行肺活检,其中 4 例发生气胸。
儿科 PPFE 的临床和放射学表现与成人相似,尽管大多数患者有治疗过的癌症史。儿童癌症治疗后数年出现限制性肺病、呼吸困难、咳嗽或自发性气胸,结合扁平胸、上叶胸膜和间隔增厚以及牵引性支气管扩张的胸部 CT 表现,可确立 PPFE 的疑似诊断。